Non-Th2 regulatory T-cell control of Th1 autoimmunity

Scandinavian Journal of Immunology

Volumn 54, Issue 1-2, 2001, Pages 21-29

  Bach, J F ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD45 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PADGEM PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; AUTOREGULATION; GENE THERAPY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOTHERAPY; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENSITIZATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANTIGENS; AUTOIMMUNITY; TH1 CELLS; TH2 CELLS;

EID: 0034957116     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00945.x     Document Type: Review

References (90)

1. Are there unique autoantigens triggering autoimmune diseases?
2. Regulatory T cells in autoimmmunity
3. The significance of immune suppression in normal self tolerance
4. Immunological tolerance of sheep to skin allografts
5. Interception of the development of self tolerance in fetal lambs
6. Acquisition of immunological self-recognition by the fetal rat
7. Curtailment of autoimmunity following parabiosis with a normal partner
8. The effect of thymectomy on lupus-prone mice
9. The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetic (NOD) mice
10. Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice
11. Experimental autoimmune orchitis after neonatal thymectomy in the mouse
12. Genetic susceptibility to post-thymectomy autoimmune diseases in mice
13. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice
14. Genetic studies on experimental autoimmune gastritis induced by neonatal thymectomy using recombinant inbred strains between a high-incidence strain, BALB/c, and a low-incidence strain, DBA/2
15. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis
16. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
17. Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
18. Susceptibility of inbred rat strains to experimental thyroiditis: Quantitation of thyroglobulin-binding cells and assessment of T-cell function in susceptible and non-susceptible strains
19. Thyroiditis in T cell-depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum
20. Spontaneous thyroiditis in thymectomized and irradiated Wistar rats
21. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential
22. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients
23. CD4+CD8-thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer
24. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25 + and CD25- subpopulations
25. Organ-specific autoimmunity induced by adult thymectomy and cyclophosphamide-induced lymphopenia
26. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice
27. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: Prevention by the OX-22low subset
28. Tolerance mechanism in experimental ovarian and gastric autoimmune diseases
29. Tolerance to islet autoantigens and type I diabetes
30. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning
31. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice
32. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells
33. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice
34. Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse
35. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
36. Characterization of peripheral regulatory CD4 (+) T cells that prevent diabetes onset in nonobese diabetic mice
37. Lack of L-selectin expression by cells transferring diabetes in NOD mice: Insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment
38. Mature mainstream TCR alpha beta (+) CD4 (+) thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse
39. Interleukin-4 deficiency does not exacerbate disease in NOD mice
40. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
41. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
42. Induction of interleukin 10-producing, nonproliferating CD4 (+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
43. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
44. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus
45. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice
46. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients
47. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
48. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
49. A novel role for TGF-beta and IL-10 in the induction of immune privilege
50. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation
51. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice
52. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1
53. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases
54. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4 (+) T cell lines
55. Regulatory T cells in the control of autoimmunity: The essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4 (+) CD45RC- cells and CD4 (+) CD8 (-) thymocytes
56. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB (low) CD4+ T cells
57. Mouse CD1-specific NK1 T cells: Development, specificity and function
58. Early quantitative and functional deficiency of NK1 (+)-like thymocytes in the NOD mouse
59. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1 + T cells that promptly produce interleukin 4
60. Overexpression of natural killer T cells protects V alpha 14-J alpha 281 transgenic nonobese diabetic mice against diabetes
61. IL-7 reverses NK1 + T cell-defective IL-4 production in the non-obese diabetic mouse
62. IL-7 up-regulates IL-4 production by splenic NK1.1(+) and NK11(-) MHC class I-like/CD1-dependent CD4 (+) T Cells
63. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance
64. CD38+ CD45RB (low) CD4+ T cells: A population of T cells with immune regulatory activities in vitro
65. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes
66. Immunologic self-tolerance maintained by CD25 (+) CD4 (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
67. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases
68. Antigen-specific therapy for autoimmune disease
69. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent
70. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
71. Inhibition of Th 1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
72. The activity of immunoregulatory T cells mediating 'active' tolerance is potentiated in NOD mice by an IL4-based retroviral gene therapy
73. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
74. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells
75. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes
76. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
77. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
78. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation
79. CTLA-4: A negative regulator of autoimmune disease
80. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse
81. Increased T cell autoreactivity in the absence of CD40- CD40 ligand interactions: A role of CD40 in regulatory T cell development
82. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity
83. Experimental autoimmune prostatitis after neonatal thymectomy in the mouse
84. Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy
85. An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus
86. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
87. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice
88. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice
89. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor- Beta 1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients
90. Extreme Th1 bias of invariant V-alpha-24J-alpha-Q T cells in type 1 diabetes